Republic of the Philippines

DOST - Health Technology Assessment

The HTAC recommends the emergency use of Sputnik V Gam-COVID-Vac to prevent COVID-19 for persons within identified priority groups aged 18 and older. Gam-COVID-Vac under emergency use The Food and Drug Administration (FDA) issues emergency use authorization (EUA) for vaccines and drugs during public health emergencies. This authorization expedites the availability of interventions for affected continue reading : HTAC Guidance for Health Care Providers: COVID-19 Vaccine Gamaleya

The Sputnik V COVID-19 Vaccine under emergency use can reduce risk against symptomatic COVID-19 for priority groups aged 18 and older, HTAC notes in a recent recommendation Gamaleya COVID-19 Vaccine under Emergency Use  The emergency use authorization of the Food and Drug Administration (FDA) (dated 19 March 2021)  allows for timely access of COVID-19 vaccines continue reading : HTAC Guidance for the General Public: COVID-19 Vaccine Gamaleya

The HTAC recommends the emergency use of SARS-CoV-2 Vaccine (Vero cell), Inactivated [CoronaVac] (commonly known as Sinovac) to prevent COVID-19 for persons aged 18 to 59 with low risk of exposure to the disease, and within identified priority groups SARS-CoV-2 Vaccine (Vero cell), Inactivated [CoronaVac] under emergency use The Food and Drug Administration (FDA) issues continue reading : HTAC Guidance for Health Care Providers : COVID-19 Vaccine Sinovac

The HTAC recommends the emergency use of SARS-CoV-2 Vaccine (Vero cell), Inactivated [CoronaVac] (commonly known as Sinovac) to prevent COVID-19 for persons aged 18 to 59 with low risk of exposure to the disease, and within identified priority groups Sinovac COVID-19 Vaccine under Emergency Use  The emergency use authorization of the Food and Drug Administration continue reading : HTAC Guidance for the General Public: COVID-19 Vaccine Sinovac